Literature DB >> 20004715

Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: Implications for psychological pathology.

Darcy Litteljohn1, Amie Cummings, Ashley Brennan, Anudip Gill, Siri Chunduri, Hymie Anisman, Shawn Hayley.   

Abstract

Pro-inflammatory cytokines promote behavioral and neurochemical variations similar to those evident following stressor exposure, and have been implicated in promoting depressive illness. Indeed, immunotherapeutic application of the cytokine, interferon-alpha, promoted depressive illness in cancer and hepatitis C patients. We assessed the possibility that another interferon cytokine family member, interferon-gamma (IFN-gamma), might contribute to the behavioral and biochemical alterations provoked by a chronic stressor regimen that has been used to model neuropsychiatric pathology in rodents. As predicted, IFN-gamma-deficient mice displayed basal differences in behavior (e.g., reduced open field exploration) and altered neurochemical activity (e.g., increased noradrenergic and serotonergic activity within the central amygdala), relative to their wild-type counterparts. Moreover, stressor-induced elevations of corticosterone and the pro-inflammatory cytokine, tumor necrosis factor-alpha, were attenuated in IFN-gamma-deficient mice. Similarly, the IFN-gamma null mice were refractory to the chronic stressor-induced alterations of dopamine metabolism (within the prefrontal cortex, paraventricular nucleus of the hypothalamus and central amygdala) evident in wild-type mice. Yet, the chronic stressor provoked signs of anxiety (e.g., reduced open field exploration) and depression-like behavior (e.g., increased forced swim immobility, reduced consumption of a palatable solution) among both wild-type and IFN-gamma knockout mice alike, suggesting a dissociation of behavioral functioning from the stressor-induced alterations of immunological, hormonal and dopaminergic activity. Together, these data suggest a complex neurobehavioral phenotype, wherein IFN-gamma deletion engenders a state of heightened basal emotionality coupled with increased monoaminergic activity in the amygdala. At the same time, however, IFN-gamma deficiency appears to blunt some of the neurochemical, corticoid and cytokine alterations ordinarily associated with chronic stressor exposure. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004715     DOI: 10.1016/j.bbi.2009.12.001

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  17 in total

1.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.

Authors:  Jennifer L Warner-Schmidt; Kimberly E Vanover; Emily Y Chen; John J Marshall; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders.

Authors:  Priscilla Martinez; Lars Lien; Sarah Zemore; Jørgen G Bramness; Sudan Prasad Neupane
Journal:  J Neuroimmunol       Date:  2018-02-22       Impact factor: 3.478

Review 3.  Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder.

Authors:  Reza Rahimian; Claudia Belliveau; Rebecca Chen; Naguib Mechawar
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

Review 4.  Immune-neural connections: how the immune system's response to infectious agents influences behavior.

Authors:  Robert H McCusker; Keith W Kelley
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

5.  The clinical implications of mouse models of enhanced anxiety.

Authors:  Simone B Sartori; Rainer Landgraf; Nicolas Singewald
Journal:  Future Neurol       Date:  2011-07-01

6.  Repeated allergic asthma in early versus late pregnancy differentially impacts offspring brain and behavior development.

Authors:  Jamie S Church; Juan M Tamayo; Paul Ashwood; Jared J Schwartzer
Journal:  Brain Behav Immun       Date:  2020-12-21       Impact factor: 7.217

Review 7.  Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases.

Authors:  Subhashini Brahadeeswaran; Narmadhaa Sivagurunathan; Latchoumycandane Calivarathan
Journal:  Mol Neurobiol       Date:  2022-01-23       Impact factor: 5.590

8.  Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes.

Authors:  Meagan Osborn; Nazneen Rustom; Melanie Clarke; Darcy Litteljohn; Chris Rudyk; Hymie Anisman; Shawn Hayley
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

9.  An in vivo animal study assessing long-term changes in hypothalamic cytokines following perinatal exposure to a chemical mixture based on Arctic maternal body burden.

Authors:  Shawn Hayley; Emily Mangano; Geoffrey Crowe; Nanqin Li; Wayne J Bowers
Journal:  Environ Health       Date:  2011-07-11       Impact factor: 5.984

10.  B-cells are abnormal in psychosocial stress and regulate meningeal myeloid cell activation.

Authors:  Mary-Ellen Lynall; Stacey L Kigar; Michael L Lehmann; Allison E DePuyt; Zewen Kelvin Tuong; Samuel J Listwak; Abdel G Elkahloun; Edward T Bullmore; Miles Herkenham; Menna R Clatworthy
Journal:  Brain Behav Immun       Date:  2021-08-08       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.